Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
The Journal of Biological Chemistry
|
May 24, 2000
The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface
D H Ho, K Badellino, F A Baglia, et al.
Anticancer Research
|
January 1, 1986
Peplomycin and bleomycin effects on human colon cancer cells
A Uematsu, D H Ho, B Drewinko, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
A radioimmunoassay for 5-methyltetrahydrohomofolate
K L Fong, D H Ho, R S Benjamin, et al.
Journal of Clinical Pharmacology
|
February 1, 1981
Clinical pharmacology of intramuscularly administered L-asparaginase
D H Ho, H Y Yap, N Brown, et al.
The Journal of Allergy and Clinical Immunology
|
April 1, 1986
Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships
G F Alberici, R Fellous, J M Bidart, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1986
Clinical pharmacology of polyethylene glycol-L-asparaginase
D H Ho, N S Brown, A Yen, et al.
Analytical Biochemistry
|
July 1, 1980
Radioimmunoassay for the detection and quantitation of bruceantin
K L Fong, D H Ho, C J Carter, et al.
Journal of Clinical Pharmacology
|
May 1, 1978
Clinica, pharmacology of tetrahydrouridine
D H Ho, G P Bodey, S W Hall, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer
N J Meropol, Y M Rustum, N J Petrelli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
The Journal of Biological Chemistry
|
May 24, 2000
The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface
D H Ho, K Badellino, F A Baglia, et al.
Anticancer Research
|
January 1, 1986
Peplomycin and bleomycin effects on human colon cancer cells
A Uematsu, D H Ho, B Drewinko, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
A radioimmunoassay for 5-methyltetrahydrohomofolate
K L Fong, D H Ho, R S Benjamin, et al.
Journal of Clinical Pharmacology
|
February 1, 1981
Clinical pharmacology of intramuscularly administered L-asparaginase
D H Ho, H Y Yap, N Brown, et al.
The Journal of Allergy and Clinical Immunology
|
April 1, 1986
Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships
G F Alberici, R Fellous, J M Bidart, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1986
Clinical pharmacology of polyethylene glycol-L-asparaginase
D H Ho, N S Brown, A Yen, et al.
Analytical Biochemistry
|
July 1, 1980
Radioimmunoassay for the detection and quantitation of bruceantin
K L Fong, D H Ho, C J Carter, et al.
Journal of Clinical Pharmacology
|
May 1, 1978
Clinica, pharmacology of tetrahydrouridine
D H Ho, G P Bodey, S W Hall, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer
N J Meropol, Y M Rustum, N J Petrelli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Page
of 12